Infectious Disease
RSSArticles
-
The Effect of Age on Cholesterol-Lowering Therapy
Investigators analyzed data on the effect of age on cardiovascular (CV) outcomes and LDL cholesterol-lowering by alirocumab vs. placebo in recent acute coronary syndrome patients. They found alirocumab can lower the rate of CV events regardless of age — and produce more absolute benefit with age.
-
Healthcare Personnel COVID-19 Hospitalizations and Vaccine Prioritization
During the period of study, 5.9% of individuals hospitalized for COVID-19-related reasons were healthcare providers (HCP), with approximately one-third involving HCP who were not expected to directly contact patients.
-
Managing Appendicitis Medically
A multicenter, randomized trial showed that 10 days of antibiotics results in comparable outcomes as surgery. Three in 10 patients treated with antibiotics required surgery within 90 days.
-
Novel COVID-19 Syndrome in Adults
Healthcare workers could be at risk of multisystem inflammatory syndrome linked to COVID-19, as the poorly understood condition, first seen in children, now is emerging in adults.
-
Are Healthcare Workers Exposing Colleagues to COVID-19?
Healthcare workers may be vigilant with personal protective equipment (PPE) around COVID-19 patients, but inadvertently expose colleagues when they take breaks, socialize, and eat.
-
Coronavirus Vaccine Hesitancy in Black and Latinx Communities
Historically, minority populations have been victimized in medical research. People of color and ethnic minorities generally are at risk of more serious outcomes if infected with SARS-CoV-2.
-
CDC: COVID’s Worst Is Yet to Come
The COVID-19 pandemic is coming to a disastrous boiling point in the United States, with one of the nation’s top public health officials predicting a high death toll as the pandemic surges nationwide over the winter months.
-
Healthcare Workers Cleared for COVID-19 Shots, Long-Term Care Residents Raise Safety Concerns
A Centers for Disease Control and Prevention advisory panel finalized COVID-19 vaccine priority for healthcare workers and long-term care residents, although the latter received the greenlight only after discussions of safety concerns that led to the one dissenting vote in a 13-1 approval.
-
FDA Approves Pfizer Vaccine for COVID-19
The Food and Drug Administration’s vaccine advisory committee has approved the use of the COVID-19 vaccine developed by Pfizer Inc. (NYC) and BioNTech (Mainz, DEU) in the United States for those ages 16 years and older. The first doses will go to healthcare workers and long-term care residents.
-
Even Moderate COVID-19 Cases Can Cause Serious Neurological Problems
Strokes, seizures, and movement disorders just a few complications observed.